{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:38:04Z","timestamp":1791171484281,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.14310\/horm.2002.1339","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T15:26:28Z","timestamp":1391181988000},"page":"126-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Statins, bone formation and osteoporosis: hope or hype?"],"prefix":"10.1007","volume":"11","author":[{"given":"Athanasios N.","family":"Tsartsalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Dokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Kaiafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris N.","family":"Tsartsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Kattamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos I.","family":"Hatzitolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos G.","family":"Savopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,1]]},"reference":[{"key":"11020126_CR1","unstructured":"Data from the World Health Organization Assessment of osteoporosis at the primary health care level. Summary report of a WHO scientific Group 2007; WHO, Geneva."},{"key":"11020126_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11926-008-0017-6","volume":"10","author":"ZA Cole","year":"2008","unstructured":"Cole ZA, Dennison EM, Cooper C, 2008 Osteoporosis epidemiology update. Curr Rheumatol Rep 10: 92\u201396.","journal-title":"Curr Rheumatol Rep"},{"key":"11020126_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1359\/jbmr.070315","volume":"22","author":"ND Nguyen","year":"2007","unstructured":"Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV, 2007 Residual lifetime risk of fractures in women and men. J Bone Miner Res 22: 781\u2013788.","journal-title":"J Bone Miner Res"},{"key":"11020126_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1590\/S0034-89102010000300011","volume":"44","author":"MM Pinheiro","year":"2010","unstructured":"Pinheiro MM, Reis Neto ET, Machado FS, et al, 2010 Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women. Rev Saude Publica 44: 479\u2013485.","journal-title":"Rev Saude Publica"},{"key":"11020126_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4158\/EP.12.4.436","volume":"12","author":"SE Painter","year":"2006","unstructured":"Painter SE, Kleerekoper M, Camacho PM, 2006 Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12: 436\u2013445.","journal-title":"Endocr Pract"},{"key":"11020126_CR6","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1210\/jc.2007-0646","volume":"92","author":"D Vega","year":"2007","unstructured":"Vega D, Maalouf NM, Sakhaee K, 2007 Clinical review: the role of receptor activator of nuclear factor kappa B(RANK)\/RANK ligand\/osteoprotegerin clinical implications. J Clin Endocrinol Metab 92: 4514\u201345121.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020126_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","volume":"30","author":"RH Cristenson","year":"1997","unstructured":"Cristenson RH, 1997 Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573\u2013593.","journal-title":"Clin Biochem"},{"key":"11020126_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","volume":"80","author":"P Meunier","year":"1971","unstructured":"Meunier P, Aaron J, Edouard C, et al, 1971 Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80: 147\u2013154.","journal-title":"A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res"},{"key":"11020126_CR9","first-page":"18","volume":"15","author":"Ch Savopoulos","year":"2011","unstructured":"Savopoulos Ch, Dokos Ch, Kaiafa Get, et al, 2011 Adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders. Hippokratia 15: 18\u201321.","journal-title":"Hippokratia"},{"key":"11020126_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0006-291X(03)01408-6","volume":"308","author":"C Song","year":"2003","unstructured":"Song C, Guo Z, Ma Q, et al, 2003 Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 308: 458\u2013462.","journal-title":"Biochem Biophys Res Commun"},{"key":"11020126_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.coph.2004.03.002","volume":"4","author":"ME Nuttall","year":"2004","unstructured":"Nuttall ME, Gimble JM, 2004 Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4: 290\u2013294.","journal-title":"Curr Opin Pharmacol"},{"key":"11020126_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","volume":"264","author":"E Van Beek","year":"1999","unstructured":"Van Beek E, Pieterman E, Cohen L, et al, 1999 Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing biphosphonates. Biochem Biophys Res Commun 264: 108\u2013111.","journal-title":"Biochem Biophys Res Commun"},{"key":"11020126_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3949\/ccjm.69.4.277","volume":"69","author":"AC Cruz","year":"2002","unstructured":"Cruz AC, Gruber LB, 2002 Statins and osteoporosis: can these lipid-lowering drugs also bolster bones? Cleve Clin J Med 69: 277\u2013288.","journal-title":"Cleve Clin J Med"},{"key":"11020126_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2010.05767.x","volume":"1218","author":"SE Papapoulos","year":"2011","unstructured":"Papapoulos SE, 2011 Use of biphosphonates in the management of postmenopausal osteoporosis. Ann N Y Acad Sci 1218: 15\u201332.","journal-title":"Ann N Y Acad Sci"},{"key":"11020126_CR15","first-page":"89","volume":"6","author":"A Rakel","year":"2011","unstructured":"Rakel A, Boucher A, Ste-Marie LG, 2011 Role of zoledronic acid in the prevention and treatment of osteoporosis. Clin Interv Aging 6: 89\u201399.","journal-title":"Clin Interv Aging"},{"key":"11020126_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/EJE-11-0740","volume":"166","author":"F Jakob","year":"2012","unstructured":"Jakob F, Oertel H, Lanqdahl B, et al, 2012 Effects of terparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-months results from the European Forsteo Observational study. Eur J Endocrinol 166: 87\u201397, Epub 2011 Nov 2.","journal-title":"Eur J Endocrinol"},{"key":"11020126_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/gme.0b013e3181e324a6","volume":"18","author":"JC Gallagher","year":"2011","unstructured":"Gallagher JC, Levine JP, 2011 Preventing osteoporosis in symptomatic postmenopausal women. Menopause 18: 109\u2013118.","journal-title":"Menopause"},{"key":"11020126_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.berh.2010.01.006","volume":"24","author":"AK Bhalla","year":"2010","unstructured":"Bhalla AK, 2010 Management of osteoporosis in a pre-menopausal women. Best Pract Res Clin Rheumatol 24: 313\u2013327.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"11020126_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00198-004-1614-5","volume":"15","author":"RN De Nijs","year":"2004","unstructured":"De Nijs RN, Jacobs JW, Alqra A, et al, 2004, Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ-transplantation studies. Osteoporos Int 15: 589\u2013602.","journal-title":"Osteoporos Int"},{"key":"11020126_CR20","first-page":"1","volume":"2","author":"R Cesare","year":"2010","unstructured":"Cesare R, Napolitano C, Lozzino M, 2010, Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal. Int J Womens Health 2: 1\u20136.","journal-title":"Int J Womens Health"},{"key":"11020126_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijcard.2009.02.001","volume":"134","author":"AI Hatzitolios","year":"2009","unstructured":"Hatzitolios AI, Athyros VG, Karagiannis A, et al, 2009 IMPROVE Collaborative Group Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study. Int J Cardiol 134: 322\u2013329.","journal-title":"Int J Cardiol"},{"key":"11020126_CR22","volume-title":"Medical Drug Reference","author":"JA Ellsworth","year":"2007","unstructured":"Ellsworth JA, Witt MD, Dugdale D, et al, Medical Drug Reference. Philadelphia: Elsevier Mosby, 2007."},{"key":"11020126_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","volume":"19","author":"BA Hmelin","year":"1998","unstructured":"Hmelin BA, Turgeon J, 1998 Hydrophilicity\/lipophlicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 19: 26\u201337.","journal-title":"Trends Pharmacol Sci"},{"key":"11020126_CR24","unstructured":"Brunton L, Lazo J. Goodman, et al, 2005 The pharmacological basis of therapeutics. McGraw-Hill."},{"key":"11020126_CR25","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1161\/01.CIR.0000023397.12047.03","volume":"105","author":"CA Yeung","year":"2002","unstructured":"Yeung CA, Tsao P, 2002 Statin therapy: beyond cholesterol lowering and antiinflamantory effects. Circulation 105: 2937\u20132938.","journal-title":"Circulation"},{"key":"11020126_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1359\/jbmr.081016","volume":"24","author":"T Srivastava","year":"2009","unstructured":"Srivastava T, Haney CJ, Alon US, 2009 Atorvastatin May Have No Effect on Acute Phase Reaction in Children After Intravenous Bisphosphonate Infusion. J Bone Miner Res 24: 334\u2013337.","journal-title":"J Bone Miner Res"},{"key":"11020126_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/01.hyp.0000126153.80112.5c","volume":"43","author":"KJ Liao","year":"2004","unstructured":"Liao KJ, 2004 Statin therapy: having the good without the bad. Hypertension 43: 1171\u20131172.","journal-title":"Hypertension"},{"key":"11020126_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-006-0282-z","volume":"18","author":"LC Hofbauer","year":"2007","unstructured":"Hofbauer LC, Brueck CC, Shanahan CM, et al, 2007 Vascular calcification and osteoporosis - from clinical observation towards molecular undestanding. Osteoporos Int 18: 251\u2013259.","journal-title":"Osteoporos Int"},{"key":"11020126_CR29","first-page":"505","volume":"18","author":"YZ Bagger","year":"2007","unstructured":"Bagger YZ, Rasmussen HB, Alexandersen P, et al, 2007 PERF Study Group. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 18: 505\u2013512.","journal-title":"Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int"},{"key":"11020126_CR30","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, et al, 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946\u20131949.","journal-title":"Science"},{"key":"11020126_CR31","first-page":"444","volume":"454","author":"SK Saraf","year":"2007","unstructured":"Saraf SK, Singh A, Garbyal RS, et al, 2007 Effect of simvastatin on fracture healing--an experimental study. Indian J Exp Biol 454: 444\u20134449.","journal-title":"Indian J Exp Biol"},{"key":"11020126_CR32","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00198-007-0412-2","volume":"18","author":"JW Wang","year":"2007","unstructured":"Wang JW, Xu SW, Yang DS, et al, 2007 Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 18: 1641\u20131650.","journal-title":"Osteoporos Int"},{"key":"11020126_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1254\/jphs.SC0070184","volume":"104","author":"M Nyan","year":"2007","unstructured":"Nyan M, Sato D, Oda M, et al, 2007 Bone Formation with the Combination of Simvastatin and Calcium.Sulfate in Critical-Sized Rat Calvarial Defect. J Pharmacol Sci 104: 384\u2013386.","journal-title":"J Pharmacol Sci"},{"key":"11020126_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2474-8-98","volume":"8","author":"B Skoglund","year":"2007","unstructured":"Skoglund B, Aspenberg P, 2007 Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord 8: 98.","journal-title":"BMC Musculoskelet Disord"},{"key":"11020126_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0501.2008.01630.x","volume":"20","author":"Z Du","year":"2009","unstructured":"Du Z, Chen J, Yan F, et al, 2009 Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Clin. Oral Implants Res 20: 145\u2013150.","journal-title":"Clin. Oral Implants Res"},{"key":"11020126_CR36","first-page":"1083","volume":"35","author":"JL Funk","year":"2008","unstructured":"Funk JL, Chen J, Downey KJ, et al, 2008 Bone Protective Effect of Simvastatin in Experimental Arthritis. J Rheumatol 35: 1083\u20131091.","journal-title":"J Rheumatol"},{"key":"11020126_CR37","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jbspin.2007.12.008","volume":"75","author":"K Pengde","year":"2008","unstructured":"Pengde K, Fuxing P, Bin S, et al, 2008 Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 75: 696\u2013701.","journal-title":"Joint Bone Spine"},{"key":"11020126_CR38","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1359\/jbmr.080603","volume":"23","author":"GE Gutierrez","year":"2008","unstructured":"Gutierrez GE, Edwards JR, Garrett IR, et al, 2008 Trans-dermal Lovastatin Enhances Fracture Repair in Rats. J Bone Miner Res 23: 1722\u20131730.","journal-title":"J Bone Miner Res"},{"key":"11020126_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1055\/s-0028-1082051","volume":"40","author":"H Kaji","year":"2008","unstructured":"Kaji H, Naito J, Inoue Y, et al, 2008 Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway. Horm Metab Res 40: 746\u2013751.","journal-title":"Horm Metab Res"},{"key":"11020126_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tripleo.2008.06.025","volume":"107","author":"S Alam","year":"2009","unstructured":"Alam S, Ueki K, Nakagawa K, et al, 2009 Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 22\u201329.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"11020126_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.maturitas.2009.03.018","volume":"63","author":"Y Uyar","year":"2009","unstructured":"Uyar Y, Baytur Y, Inceboz U, et al, 2009 Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Maturitas 63: 261\u2013267.","journal-title":"Maturitas"},{"key":"11020126_CR42","first-page":"581","volume":"23","author":"R Hanayama","year":"2009","unstructured":"Hanayama R, Shimizu H, Nakagami H, et al, 2009 Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action. Int J Mol Med 23: 581\u2013588.","journal-title":"Int J Mol Med"},{"key":"11020126_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.tripleo.2008.07.013","volume":"107","author":"Y Ayukawa","year":"2009","unstructured":"Ayukawa Y, Yasukawa E, Moriyama Y, et al, 2009 Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107: 336\u2013342.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"11020126_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2362.2009.02092.x","volume":"39","author":"ML Ho","year":"2009","unstructured":"Ho ML, Chen YH, Liao HJ, et al, 2009 Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats. Eur J Clin Invest 39: 296\u2013303.","journal-title":"Eur J Clin Invest"},{"key":"11020126_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bone.2009.05.010","volume":"45","author":"S Pauly","year":"2009","unstructured":"Pauly S., Luttosch F, Morawski M, et al, 2009 Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone 45: 505\u2013511.","journal-title":"Bone"},{"key":"11020126_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4248\/ijos.08011","volume":"1","author":"C Liu","year":"2009","unstructured":"Liu C, Wu Z, Sun HC, 2009 The Effect of Simvastatin on mRNA Expression of Transforming Growth Factor-\u03b21, Bone Morphogenetic Protein-2 and Vascular Endothelial Growth Factor in Tooth Extraction Socket Int J Oral Sci 1: 90\u201398.","journal-title":"Int J Oral Sci"},{"key":"11020126_CR47","first-page":"509","volume":"33","author":"SH Chen","year":"2010","unstructured":"Chen SH, Chou FF, Ko JY, 2010 The Use of Simvastatin with Aromasin in an Ovariectomized Rat Model: Effects on the Skeletal System. Chang Gung Med J 33: 509\u2013514.","journal-title":"Chang Gung Med J"},{"key":"11020126_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-0501.2008.01639.x","volume":"20","author":"M Nyan","year":"2009","unstructured":"Nyan M, Sato D, Kihara H, et al, 2009 Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration. Clin Oral Implants Res 20: 280\u2013287.","journal-title":"Clin Oral Implants Res"},{"key":"11020126_CR49","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jbmr.42","volume":"25","author":"W Wang","year":"2010","unstructured":"Wang W, Nyman JS, Moss HE, et al, 2010 Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Nf1 Loss of Function in Osteoblasts J Bone Miner Res 25: 1658\u20131667.","journal-title":"J Bone Miner Res"},{"key":"11020126_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/S0103-64402010000300003","volume":"21","author":"P Goes","year":"2010","unstructured":"Goes P, Lima AP, Melo IM, et al, 2010 Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats. Braz Dent J 21: 193\u2013198.","journal-title":"Braz Dent J"},{"key":"11020126_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1590\/S1806-83242011000100008","volume":"25","author":"CE Lima","year":"2011","unstructured":"Lima CE, Calixto JC, Anbinder AR, 2011 Influence of the association between simvastatin and demineralized bovine bone matrix on bone repair in rats Braz Oral Res 25: 42\u201348.","journal-title":"Braz Oral Res"},{"key":"11020126_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00223-007-9078-1","volume":"81","author":"A Hughes","year":"2007","unstructured":"Hughes A, Rogers MJ, Idris AI, et al, 2007 A Comparison between the Effects of Hydrophobic andHydrophilic Statins on Osteoclast Function In Vitro and Ovariectomy-Induced Bone Loss In Vivo. Calcif Tissue Int 81: 403\u2013413.","journal-title":"Calcif Tissue Int"},{"key":"11020126_CR53","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/jcb.21259","volume":"101","author":"S Ruiz-Gaspa","year":"2007","unstructured":"Ruiz-Gaspa S, Nogues X, Enjuanes A, et al, 2007 Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem 101: 1430\u20131438.","journal-title":"J Cell Biochem"},{"key":"11020126_CR54","first-page":"1733","volume":"123","author":"KS Ahn","year":"2008","unstructured":"Ahn KS, Sethi G, Chaturvedi MM, et al, 2008 Simvastatin. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer 123: 1733\u20131740.","journal-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer"},{"key":"11020126_CR55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1677\/JOE-07-0532","volume":"196","author":"M Yamashita","year":"2008","unstructured":"Yamashita M, Otsuka F, Mukai T, et al, 2008 Simvastatin antagonizes tumor necrosis factor-a inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras\/ Rho-mitogen-activated protein kinase pathway. J Endocrinol 196: 601\u2013613.","journal-title":"J Endocrinol"},{"key":"11020126_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1159\/000322332","volume":"26","author":"M Monjo","year":"2010","unstructured":"Monjo M, Rubert M, Ellingsen JE, et al, 2010 Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells. Cell Physiol Biochem 26: 647\u2013656.","journal-title":"Cell Physiol Biochem"},{"key":"11020126_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.regpep.2010.03.003","volume":"162","author":"M Yamashita","year":"2010","unstructured":"Yamashita M, Otsuka F, Mukai T, et al, 2010 Simvastatin inhibits osteoclast differentiation induced by bone morphogeneticprotein-2 and RANKL through regulating MAPK, AKT and Src signaling Regulatory Peptides 162: 99\u2013108.","journal-title":"Regulatory Peptides"},{"key":"11020126_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nutres.2010.03.004","volume":"30","author":"PY Chen","year":"2010","unstructured":"Chen PY, Sun JS, Tsuang YH, et al, 2010 Simvastatin promotes osteoblast viability and differentiation via Ras\/Smad\/Erk\/BMP-2 signaling pathway. Nutr Res 30: 191\u2013199.","journal-title":"Nutr Res"},{"key":"11020126_CR59","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1016\/j.biomaterials.2010.03.037","volume":"31","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Ni Y, Liu Y, et al, 2010 The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 31: 5325\u20135335.","journal-title":"Biomaterials"},{"key":"11020126_CR60","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/jbmr.163","volume":"25","author":"J Pagkalos","year":"2010","unstructured":"Pagkalos J, Cha JM, Kang Y, et al, 2010 Simvastatin induces osteogenic differentiation of murine embryonic stem cells. J Bone Miner Res, 25: 2470\u20132478.","journal-title":"J Bone Miner Res"},{"key":"11020126_CR61","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","volume":"40","author":"B Uzzan","year":"2007","unstructured":"Uzzan B, Cohen R, Nicolas P, et al, 2007 Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40: 1581\u20131587.","journal-title":"Bone"},{"key":"11020126_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4158\/EP.13.2.114","volume":"13","author":"AR Uysal","year":"2007","unstructured":"Uysal AR, Delibasi T, Erdogan MF, et al, 2007 Effect of simvastatin use on bone mineral density in women with type 2 diabetes. Endocr Pract 13: 114\u2013116.","journal-title":"Endocr Pract"},{"key":"11020126_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1507\/endocrj.K06-127","volume":"54","author":"T Majima","year":"2007","unstructured":"Majima T, Komatsu Y, Fukao A, et al, 2007 Short term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. Endocr J 54: 145\u2013151.","journal-title":"Endocr J"},{"key":"11020126_CR64","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2169\/internalmedicine.46.0419","volume":"46","author":"T Majima","year":"2007","unstructured":"Majima T, Shimatsu A, Komatsu Y, et al, 2007 Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia. Intern Med, 46: 1967\u20131973.","journal-title":"Intern Med"},{"key":"11020126_CR65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00592-007-0246-6","volume":"44","author":"H Safaei","year":"2007","unstructured":"Safaei H, Janghorbani M, Aminorroaya A, et al, 2007 Lovastatin effects on bone mineral density in post-menopausal women with type 2 diabetes mellitus. Acta Diabetol 44: 76\u201382.","journal-title":"Acta Diabetol"},{"key":"11020126_CR66","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1210\/jc.2006-1909","volume":"92","author":"HG Bone","year":"2007","unstructured":"Bone HG, Kiel DP, Lindsay RS, et al, 2007 Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial. J Clin Endocrinol Metab 92: 4671\u20134677.","journal-title":"J Clin Endocrinol Metab"},{"key":"11020126_CR67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000170886","volume":"53","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2008","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Vega G, Abad L, et al, 2008 Effect of the TNFalpha-308 G\/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome. Ann Nutr Metab 53: 117\u2013121.","journal-title":"Ann Nutr Metab"},{"key":"11020126_CR68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jor.20572","volume":"27","author":"S Patil","year":"2009","unstructured":"Patil S, Holt G, Raby N, et al, 2009 Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing. J Orthop Res 27: 281\u2013285.","journal-title":"J Orthop Res"},{"key":"11020126_CR69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10557-009-6181-8","volume":"23","author":"B Yavuz","year":"2009","unstructured":"Yavuz B, Ertugrul DT, Cil H, et al, 2009 Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 23: 295\u2013299.","journal-title":"Cardiovasc Drugs Ther"},{"key":"11020126_CR70","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2169\/internalmedicine.48.2645","volume":"48","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamauchi M, et al, 2009 Rosuvastatin Increased Serum Osteocalcin Levels Independent of Its Serum Cholesterol-Lowering Effect in Patients with Type 2 Diabetes and Hypercholesterolemia. Intern Med 48: 1869\u20131873.","journal-title":"Intern Med"},{"key":"11020126_CR71","first-page":"1011","volume":"46","author":"S Chuengsamarn","year":"2010","unstructured":"Chuengsamarn S, Rattanamongkoulgul S, Suwanwalaikorn S, et al, 2010 Effects of statins vs. non-statin lipidlowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone 46: 1011\u20131015.","journal-title":"non-statin lipidlowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone"},{"key":"11020126_CR72","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archinte.164.2.146","volume":"164","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Mundy GR, Jamal SA, et al, 2004 Use of Statins and Fracture. Arch Intern Med 164: 146\u2013152.","journal-title":"Arch Intern Med"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1339\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:36:18Z","timestamp":1739115378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["11020126"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1339","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"25 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}